FRCA Notes


Diabetic Ketoacidosis


  • DKA is a medical emergency, characterised by the triad of:
  1. Blood glucose >11mmol/L or known diabetes mellitus
  2. Blood ketones ≥3mmol/L or ketonuria ≥2+
  3. Venous pH <7.3 and/or bicarbonate <15mmol/L
  • It remains a frequent and life-threatening complication of both type 1 and type 2 diabetes
  • Euglycaemic DKA, often associated with SGLT2 inhibitors, meets the same criteria but with glucose <11mmol/L

Epidemiology

  • 13% of patients admitted with a primary diagnosis of DKA require ICU admission
  • DKA represents ~2% of all ICU admissions
  • ~0.5% of inpatients with diabetes develop DKA and hospital-acquired DKA is a leading cause of preventable inpatient harm

Aetiology

  • Typically one of:
    • A first presentation of diabetes
    • Infection or another inflammatory insult, including acute coronary syndromes and surgery
    • Missed or inadequate insulin, particularly in hospital-acquired DKA
  • Drugs affecting glucose metabolism: SGLT2 inhibitors, steroids, catecholamines, thiazides, antipsychotics
  • Pregnancy, alcohol and starvation predispose to euglycaemic DKA

  • There is:
    • A relative or absolute insulin deficiency
    • An increase in counter-regulatory hormones: glucagon, catecholamines, cortisol and growth hormone
  • ↑ gluconeogenesis and glycogenolysis with impaired peripheral glucose uptake cause hyperglycaemia

  • Unrestrained lipolysis releases free fatty acids, which undergo hepatic β-oxidation to ketone bodies:
    • β-hydroxybutyrate (predominant)
    • Acetoacetate
    • Acetone
  • There is thus ketosis

  • Ketone bodies dissociate, releasing H+ and causing a high anion gap metabolic acidosis

  • Hyperglycaemia also causes:
    • Osmotic shift of water from the intracellular to the extracellular compartment
    • Glycosuria once the renal threshold is exceeded (see renal glucose handling)
    • Osmotic diuresis with dehydration and loss of Na+, K+, phosphate and magnesium
  • Further detail is on the diabetes physiology page

  • There is a broad spectrum of presentation
  • Onset is generally more rapid than HHS, and acidosis is the dominant feature

Respiratory Cardiovascular Neurological Renal and metabolic Gastrointestinal
Breathlessness Tachycardia Reduced consciousness Polyuria and polydipsia Abdominal pain
Kussmaul breathing Hypotension Confusion or agitation AKI Nausea and vomiting
Hypocapnia Dehydration Cerebral oedema (rare) High anion gap acidosis Ileus and delayed gastric emptying
Ketotic breath Pseudohyponatraemia


Establish the diagnosis

  1. Capillary blood glucose
  2. Capillary blood ketones (β-hydroxybutyrate); preferred to urinary ketones, which detect acetoacetate and underestimate ketosis (see glucose and ketone meters)
  3. Venous blood gas for pH and bicarbonate; arterial sampling is unnecessary unless there are respiratory concerns

Identify the precipitant

  • Infection screen: FBC, CRP, cultures, urinalysis, chest X-ray
  • Exclude other causes of abdominal pain: pregnancy test, amylase, LFTs
  • ECG ± troponin if acute coronary syndrome suspected
  • Drug history, specifically insulin adherence and SGLT2 inhibitors

Monitoring

  • U&E for electrolyte derangement and AKI
  • Ketones, glucose, pH, bicarbonate and potassium: ketones and glucose hourly, venous gas at least 2-hourly initially
  • Glucose is a poor marker of severity and of response, especially in euglycaemic DKA; treatment is guided by ketone clearance


DKA HHS
Typical patient Type 1 diabetes, younger Type 2 diabetes, older
Onset Hours Days
Glucose >11mmol/L (or normal in euglycaemic DKA) Usually ≥30mmol/L
Ketones ≥3mmol/L <3mmol/L
pH / bicarbonate pH <7.3 and/or HCO3- <15mmol/L pH >7.3 and/or HCO3- >15mmol/L
Osmolality Variable ≥320mOsm/kg
Fluid deficit ~100ml/kg ~100-220ml/kg
Insulin FRII 0.1units/kg/hr from the start FRII 0.05units/kg/hr only once glucose stops falling with fluids alone, or if ketones >1mmol/L

  • Mixed DKA/HHS presentations can occur

  • An initial ABCDE approach, targeting SpO2 94-98%, with at least two large-bore cannulae and treatment of the precipitant
  • Involve the diabetes specialist team early

Fluid resuscitation

  • Fluid replacement is the most important initial intervention, as the water deficit is ~100ml/kg
  • Use crystalloid with [Na+] 130-154mmol/L, i.e. 0.9% saline or a balanced crystalloid
    • Balanced crystalloids may resolve acidosis slightly faster with less hyperchloraemia, but outcomes are largely similar (QJM, 2011)
    • Outside higher care areas 0.9% saline with added potassium is typically used, as balanced crystalloids do not contain enough potassium
  • Tailor volume to the patient's comorbidities (e.g. heart failure, renal failure, frailty), response and urine output

Fixed rate intravenous insulin infusion (FRII)

  • Start once fluids are running: 0.1units/kg/hr of soluble insulin (50units Actrapid or Humulin S in 50ml 0.9% saline), using actual or estimated weight
  • A fixed rate avoids down-titration based on falling glucose while the patient is still ketotic
  • Targets:
    • Fall in blood ketones of ≥0.5mmol/L/hr
    • Rise in venous bicarbonate of ≥3mmol/L/hr
    • Fall in blood glucose of ≥3mmol/L/hr

  • If targets are not met:
    • Check the infusion and cannula
    • Increase the FRII by 1unit/hr (maximum 15units/hr)
    • Seek senior review

  • Continue until DKA has resolved: ketones <0.6mmol/L and venous pH >7.3
  • Before stopping, ensure subcutaneous insulin is given
  • If not eating and drinking, convert to a VRII with substrate fluid (see diabetes mellitus)

Potassium

  • The total body K+ deficit is 3-5mmol/kg, although serum K+ may initially be normal or high
  • Insulin drives K+ into cells, so hypokalaemia commonly develops during treatment
  • If K+ is:
    • <3.5mmol/L: consider central potassium replacement
    • 3.5 - 5.5mmol/L: add 40mmol KCl to fluids
    • >5.5mmol/L: omit potassium (also omit if anuric)
  • Sodium, chloride, phosphate and bicarbonate deficits usually correct with treatment and bicarbonate therapy is not routinely recommended

Glucose and background insulin

  • Once glucose is <14mmol/L, add 10% glucose at 125ml/hr alongside the resuscitation fluid to prevent hypoglycaemia while ketones clear
  • In euglycaemic DKA, start 10% glucose immediately and if glucose still falls, reduce the FRII to 0.05units/kg/hr
  • Continue long-acting basal insulin throughout, to ease transition to subcutaneous insulin and prevent rebound ketosis
  • Stop and disconnect insulin pumps during DKA and restart only with diabetes team input
  • SGLT2 inhibitors should be stopped and not restarted without specialist review

Supportive management

  • Consider a nasogastric tube if consciousness is reduced or vomiting, as ketosis delays gastric emptying
  • Urinary catheter to monitor urine output, particularly if critically ill or oliguric
  • Antibiotics if infection is a likely precipitant
  • VTE prophylaxis, given the prothrombotic state of dehydration

Critical care referral


Criteria Value
SpO2 <92% on air
HR
SBP
<60bpm or >100bpm
<90mmHg
GCS <12
Potassium <3.5mmol/L on admission
Acidaemia Ketones >6mmol/L
pH <7.0
Bicarbonate <5mmol/L
Anion gap >16

  • Referral does not necessarily mean admission, but these features indicate severe DKA


Complications of DKA
Hypokalaemia and hypoglycaemia
Hyperchloraemic acidosis
Acute kidney injury
Pulmonary oedema
Cerebral oedema
Venous thromboembolism
Aspiration
Death

Cerebral oedema

  • The most common cause of death from DKA in children, and rare in adults
  • Thought to arise from cerebral hypoperfusion followed by reperfusion injury and vasogenic oedema, rather than osmotic shifts alone

Patient factors Treatment factors Other factors
Young age >40ml/kg fluid in the first 4hrs Raised urea
New diagnosis of diabetes Hypotonic fluid Initial pH <7.1
Insulin boluses or insulin in the first hour Severe hypocapnia
Bicarbonate therapy

  • A clinical diagnosis: headache, altered mental state, cranial nerve palsies or Cushing's triad
  • Treat immediately with 3% hypertonic saline (3-5ml/kg) or mannitol (0.5-1g/kg), then arrange urgent CT

Mortality

  • Overall mortality has fallen to <1%, but remains >5% in the elderly and comorbid
  • Concurrent sepsis, pneumonia, ARDS or myocardial infarction increase mortality

Peri-operative management of the patient with DKA requiring surgery


  • Some patients have a surgical precipitant for their DKA that requires intervention
  • Ensure the 'acute abdomen' is not simply a feature of DKA itself, which often resolves with treatment
  • Surgery should be deferred until DKA is treated, unless immediately life, limb or organ-saving

  • Optimise as far as time allows, with senior anaesthetic and critical care involvement
  • Continue the FRII, fluids, potassium and glucose infusions
  • Central venous access is likely to be needed for:
    • DKA resuscitation fluid with KCl via a pump
    • FRII via a pump
    • 10-20% glucose once glucose <14mmol/L
    • Intra-operative fluids and drugs
    • Concentrated KCl if hypokalaemic
  • Correct hypokalaemia before induction where possible

Monitoring

  • Standard AAGBI monitoring with an arterial line for continuous blood pressure and frequent sampling
  • Glucose, ketones, potassium and pH at least hourly

Anaesthetic technique

  • High aspiration risk from delayed gastric emptying:
    • Aspirate a nasogastric tube before induction
    • Rapid sequence induction
  • Cardiovascularly stable induction, as hypovolaemia and acidosis exaggerate hypotension
  • Avoid succinylcholine if hyperkalaemic
  • Controlled ventilation matching the patient's compensatory hyperventilation, to avoid worsening acidosis with a rise in PaCO2

Metabolic management

  • Continue the FRII, adding 10% glucose once CBG <14mmol/L
  • Replace potassium as needed

  • Higher care area (HDU or ICU)
  • Continue DKA management until resolution, then transition to subcutaneous insulin with diabetes team input